atibuclimab   Click here for help

GtoPdb Ligand ID: 11326

Synonyms: IC14
Immunopharmacology Ligand
Compound class: Antibody
Comment: Atibuclimab (IC14) is a monoclonal antibody against CD14 [1]. It was developed by ICOS Corporation (acquired by Eli Lilly) and is being progressed in COVID-19 by Implicit Bioscience.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CD14 molecule Hs Antibody Binding - - - 1,4
[1,4]